Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Time Medical International Ventures (India) Pvt Ltd, awholly owned subsidiary of the Company enters Indonesia through TB EradicationPartnership with the City of Jember".
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited announced that its wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has expanded into Indonesia. The entry is through a Tuberculosis (TB) Eradication Partnership with the City of Jember, as stated in a press release dated December 01, 2025. This marks the subsidiary's international foray into Indonesia's healthcare segment, specifically targeting TB control initiatives. The partnership with a municipal authority suggests a government-linked or public health-oriented collaboration.
This is a positive development indicating international business expansion for the subsidiary, potentially opening a new revenue stream in Indonesia's healthcare market. Short-term stock impact may be limited as financial terms and scale of the partnership were not disclosed, but it signals strategic growth in the medical/healthcare vertical.